Sanofi SA
MIL:1SAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
MIL:1SAN
|
FR |
|
K
|
Korea Petro Chemical Ind Co Ltd
KRX:006650
|
KR |
|
C
|
China Industrial Group Inc
OTC:CIND
|
US |
|
X
|
Xiamen Changelight Co Ltd
SZSE:300102
|
CN |
|
A
|
African Equity Empowerment Investments Ltd
JSE:AEE
|
ZA |
|
J
|
JATT Acquisition Corp
F:1GU
|
KY |
|
L
|
LGB Forge Ltd
NSE:LGBFORGE
|
IN |
|
P
|
Plum Acquisition Corp. IV
NASDAQ:PLMK
|
US |
|
Oppenheimer Holdings Inc
NYSE:OPY
|
US |
|
C
|
CFM Holdings Ltd
SGX:5EB
|
SG |
|
Indian Hume Pipe Company Ltd
NSE:INDIANHUME
|
IN |
|
H
|
Healthlead PCL
SET:HL
|
TH |
|
J
|
Jiangsu Changqing Agrochemical Co Ltd
SZSE:002391
|
CN |
|
Naigai Co Ltd
TSE:8013
|
JP |
|
4imprint Group PLC
LSE:FOUR
|
UK |
|
MNC Vision Networks Tbk PT
IDX:IPTV
|
ID |
|
N
|
Novatek PAO
LSE:NVTK
|
RU |
|
C
|
CCL Industries Inc
TSX:CCL.B
|
CA |
|
Allianz SE
XETRA:ALV
|
DE |
|
Heads UP Ventures Limited
NSE:HEADSUP
|
IN |
|
S
|
Shaanxi Huaqin Technology Industry Co Ltd
SSE:688281
|
CN |
|
H
|
Hexagon Purus ASA
OSE:HPUR
|
NO |
|
A
|
AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
SET:AIMIRT
|
TH |
|
R
|
Reditus Sociedade Gestora de Participacoes Sociais SA
ELI:RED
|
PT |
Multiples-Based Value
The Multiples-Based Value of one
1SAN
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 79.76 EUR,
Sanofi SA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
1SAN Competitors Multiples
Sanofi SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
MIL:1SAN
|
96.8B EUR | 2.1 | 12.6 | 10.6 | 10.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.5 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.6 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.4 | 15.7 | 22.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20.3 | 7.8 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.9 | 7.1 | 8.8 |